| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > Marketing: The Cats & Dogs Of It |
|
Digg It - Marketing: The Cats & Dogs Of It
For some time I’ve struggled to come up with a way of distinguishing direct from indirect marketing, if According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product only to help participants in my seminars. Typically, we think of indirect marketing as all of those a ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ctivities that create customer awareness, fuzzy feelings, and a positive predisposition to buy, which c lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. lminates in a customer deciding to contact us. Direct marketing is when we send them a mailer or call here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe them on the phone or run an ad on radio or TV, beckoning them to come into our stores or to call our “8 d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro 0” numbers. With indirect, they come to us, and with direct, we go to them. I had just finished admon ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ishing my dog to stay back while I parked in the driveway, and he obeyed, dutifully. Then I went indoor easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi , cooked some salmon, and one of the cats I feed meowed that she wanted to come in for a bite and back- nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically scratching. Then, it hit me. Direct marketing is like dog training. You have to issue commands, repea and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ edly, to get them to learn what you want, and to then respond. But once you have the drill down, they t ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi end to keep complying as long as the stimulus and the reward remain the same. Indirect marketing is li ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ke befriending a cat. You can’t be too direct, or you scare them off. You make it comfortable for them dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod o get to know you, and then, if you’re lucky, you might earn the chance to feed them for the rest of th cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin eir lives, getting in return, a most gratifying morsel of affection. Dog training is reliable. You can tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen do it in a park, in a pack arrangement with other clueless owners. It’s called Obedience School. Cats? t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel Well, obedience just isn’t in their vocabularies. There are satisfactions in both arrangements. My Be ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust rded Collie, a rescue dog, is a slobbering fuzz ball who loves to dig and jump on me. Cleopa, a former y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products member of a feral cat colony, and occasional recidivist, is unusually affectionate and has a huge vocab . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de lary, considering. But she might not say hello for a day or two. Take your pick, or if you’re like me, elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip enjoy both. But don’t expect indirect marketing to carry your newspaper. It just isn’t that compliant tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:What Kind of a Job is Best for a Creative Genius? Six Useful Strategies for Navigating Career Transition or Job Change [And Other Big Changes as Well]
|